These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function. Sener A; Bella AJ; Nguan C; Luke PP; House AA Clin Transplant; 2009; 23(1):96-100. PubMed ID: 19200221 [TBL] [Abstract][Full Text] [Related]
9. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation. Audard V; Kamar N; Sahali D; Cardeau-Desangles I; Homs S; Remy P; Aouizerate J; Matignon M; Rostaing L; Lang P; Grimbert P Transpl Int; 2012 May; 25(5):e62-6. PubMed ID: 22409658 [TBL] [Abstract][Full Text] [Related]
10. Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient. Sakai K; Takasu J; Nihei H; Yonekura T; Aoki Y; Kawamura T; Mizuiri S; Aikawa A Clin Transplant; 2010 Jul; 24 Suppl 22():60-5. PubMed ID: 20590697 [TBL] [Abstract][Full Text] [Related]
11. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation. Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947 [TBL] [Abstract][Full Text] [Related]
12. Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation. Gonzalez E; Ettenger R; Rianthavorn P; Tsai E; Malekzadeh M Pediatr Transplant; 2011 Aug; 15(5):495-501. PubMed ID: 21338460 [TBL] [Abstract][Full Text] [Related]
13. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Peters HP; van de Kar NC; Wetzels JF Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266 [TBL] [Abstract][Full Text] [Related]
14. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Meyer TN; Thaiss F; Stahl RA Transpl Int; 2007 Dec; 20(12):1066-71. PubMed ID: 17887957 [TBL] [Abstract][Full Text] [Related]
15. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation. Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013 [TBL] [Abstract][Full Text] [Related]
16. Rituximab for post-transplant recurrences of FSGS. Bayrakci US; Baskin E; Sakalli H; Karakayali H; Haberal M Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107 [TBL] [Abstract][Full Text] [Related]
17. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091 [TBL] [Abstract][Full Text] [Related]
18. Outcomes after renal transplantation for FSGS in children. Baum MA Pediatr Transplant; 2004 Aug; 8(4):329-33. PubMed ID: 15265156 [TBL] [Abstract][Full Text] [Related]
19. Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation. Apeland T; Hartmann A Nephrol Dial Transplant; 2008 Jun; 23(6):2091-4. PubMed ID: 18319357 [No Abstract] [Full Text] [Related]
20. Therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis following transplantation. Shariatmadar S; Noto TA J Clin Apher; 2002; 17(2):78-83. PubMed ID: 12210710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]